BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Evinova, Lothar Medical Partner to Digitise Respiratory Clinical Trials

Evinova, a global leader in AI-native clinical development technology, announced a strategic partnership with Lothar Medical to help transform the ex...

September 08, 2026 | News

Alteogen, Novartis Ink Up to $3.2B Deal for Subcutaneous Biologics Using ALT-B4

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreem...

September 04, 2026 | News

EpiVax Adds AI-Enabled Enhancements to ISPRI Immunogenicity Risk Platform

EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the ...

September 04, 2026 | News

IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400...

September 03, 2026 | News

Singapore Becomes First ASEAN Market to Subsidise Vutrisiran for ATTR Amyloidosis

"From September 2026 – eligible patients receiving vutrisiran will receive government subsidies of up to 75%[1],[2]" "HELIOS-A and B provide strong ...

September 02, 2026 | News

Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum

Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical inno...

September 01, 2026 | News

DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...

August 31, 2026 | News

Monod Bio, SignalChem Biotech Ink Licensing Deal to Advance AI-Designed Protein Technologies

Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. announced a n...

August 28, 2026 | News

Biosidus Expands Biologics Manufacturing Capacity with New Bioreactor Plant in Argentina

Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announ...

August 28, 2026 | News

GenScript CEO Sherry Shao Sees AI-Enabled Drug Discovery as Key Growth Engine After Strong H1 2026

Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue GenScript Biotech Corporation (HKEX: 154...

August 20, 2026 | Company results

Henlius, Sandoz Expand Global Biosimilars Alliance with Up to 10 New Antibody Assets

Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs...

August 18, 2026 | News

6 Radiopharmaceutical Programmes and Sites to Watch in APAC

Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six an...

August 18, 2026 | Analysis

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

Thermo Fisher Scientific and KYAN Technologies have signed a Memorandum of Understanding (MoU) to collaborate on advancing functional precision oncology ap...

August 14, 2026 | News

SingHealth Launches Global Fellowship Network to Develop Future-Ready Healthcare Leaders

SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healt...

August 14, 2026 | News

Stay Connected